Press releases
- CV Sciences, Inc. Reports First Quarter 2024 Financial Results
- CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
- CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
- CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
- CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
- CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
More ▼
Key statistics
On Wednesday, CV Sciences Inc (0HRT:LSE) closed at 0.10, 0.00% below its 52-week high of 0.10, set on Jun 05, 2024.
52-week range
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.10 |
Average volume | 16.13k |
---|---|
Shares outstanding | 163.23m |
Free float | 163.20m |
P/E (TTM) | -- |
Market cap | 13.06m USD |
EPS (TTM) | -0.0207 USD |
Data delayed at least 20 minutes, as of Jun 05 2024 17:27 BST.
More ▼